RTI International wins FDA approval for pretomanid for treating drug-resistant TB

AstraZeneca gains FDA Breakthrough Therapy Designation for Calquence for chronic lymphocytic leukaemia

LEO Pharma A/S Acquires Rights to Develop and Market brodalumab for Moderate-to-Severe Psoriasis Outside of Europe

Alnylam Pharmaceutical, Ironwood Pharmaceuticals Enter US GI Disease Education and Promotional Agreement for Alnylam's Givosiran in Acute Hepatic Porphyria

Janssen Gains European Commission Approval of Imbruvica for Expanded Use in Two Indications

Deciphera Pharmaceuticals Reports Positive Updated Phase 1 Data for Ripretinib in Gastrointestinal Stromal Tumors

Regeneron Pharmaceuticals Inc wins US FDA approval for the EYLEA Injection prefilled syringe for macular degeneration and macular edema

DynoSense Corp passes US FDA approval for the cloud based vital signs measurement system

Duchesnay USA launches new Osphena website

AtriCure closes acquisition of SentreHEART

Shimadzu Medical Systems marks FDA approved FLUOROspeed X1 RF system

Calliditas announces exclusive in-licensing related to autoimmune hepatitis in the US market

Ligand Partner CASI Pharmaceuticals Launches EVOMELA in China

Kala Pharmaceuticals Receives FDA Complete Response Letter for KPI-121 0.25% NDA and Plans to Respond with Data From STRIDE 3 Trial

First Patient Enrolled in CARES10, a Phase 3, Multi-Center Study to Assess a 10 % Intravenous Immunoglobulin in Adults with Primary Immunodeficiency Disease